Profire Energy, Inc. (NASDAQ:PFIE) shares moved down -0.95% in last trading session and ended the day at $1.04. PFIE Gross Margin is 51.40% and its has a return on assets of 6.20%. Profire Energy, Inc. (NASDAQ:PFIE) quarterly performance is -18.11%.
Profire Energy, Inc. is an oilfield technology company. The Company is primarily engaged in the business of developing combustion management technologies for the oil and gas industry. The Company specializes in the creation of burner-management systems, used on a range of oilfield natural-draft fire tube vessels, and primarily sells its products and services throughout North America.
Profire Energy, Inc. (NASDAQ:PFIE), a technology company, which creates, installs and services oilfield burner and chemical management solutions in the oil and gas industry, announced the appointment of Mr. Ryan W. Oviatt as its new Chief Financial Officer, effective September 14. Oviatt succeeds Mr. Andrew Limpert, who recently stepped down from his roles as CFO and Director.
E-Commerce China Dangdang Inc. (NYSE:DANG) ended the last trading day at $6.09. Company weekly volatility is calculated as 3.71% and price to cash ratio as 1.91. E-Commerce China Dangdang Inc. (NYSE:DANG) showed a weekly performance of -2.25%.
E-Commerce China Dangdang Inc. is a holding company. The Company is a business-to-consumer (B2C) e-commerce company in the People’s Republic of China. The Company is principally engaged in the sales of books, audio-visual products, periodicals, consumer electronics and other general merchandise on the Internet. The Company’s other media products and selected general merchandise categories include fashion and apparel beauty and personal care products, home and lifestyle products, and baby, children and maternity products.
E Commerce China Dangdang (NYSE:DANG) was downgraded by Zacks from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, Market Beat.com reports.
On 11 September, Overstock.com Inc. (NASDAQ:OSTK) shares moved down -1.20% and was closed at $19.71. OSTK EPS growth in last 5 year was 1.80%. Overstock.com Inc. (NASDAQ:OSTK) year to date (YTD) performance is -18.79%.
Overstock.com, Inc. (Overstock) is an online retailer offering discount brand name, non-brand name and closeout merchandise, including furniture, home decor, bedding and bath, housewares, jewelry and watches, apparel and designer accessories, electronics and computers, and sporting goods, among other products. The Company also sells books, magazines, compact discs (CDs), digital versatile discs (DVDs) and video games (BMMG).
On 1st September, Klarna, Europe’s leading payment solutions providers, announced the official launch of commercial operations in the U.S. with Overstock.com Inc. (NASDAQ:OSTK) as its first major retail partner. According to Overstock.com, this partnership will bring a simplified buying experience on mobile devices, enabling Overstock.com shoppers the ease of buying from their smartphone or tablet with just one tap.
Natuzzi SpA (NYSE:NTZ) shares fell -5.11% in last trading session and ended the day at $1.67. NTZ Gross Margin is 28.00% and its has a return on assets of -12.80%. Natuzzi SpA (NYSE:NTZ) quarterly performance is -20.10%.
Natuzzi S.p.A. (Natuzzi) is primarily engaged in the design, manufacture and marketing of contemporary and traditional leather and fabric-upholstered furniture, principally sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, and living room accessories. It sells its Natuzzi furniture principally through franchised Divani & Divani by Natuzzi and Natuzzi furniture stores. As of March 31, 2010, Natuzzi sells its furniture in various locations, which include 124 Divani & Divani by Natuzzi and 174 Natuzzi stores, of which 56 are directly owned by the Company; eight outlets, and 17 concessions in the United Kingdom and Republic of Ireland.
Clovis Oncology, Inc. (NASDAQ:CLVS) caters to the Healthcare space. Its weekly performance is 27.90%. On the last day of trading company shares ended up $104.10. Clovis Oncology, Inc. (NASDAQ:CLVS) distance from 50-day simple moving average (SMA50) is 26.53%.
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.
Clovis Oncology (NASDAQ:CLVS) announced that rociletinib, the company’s oral targeted covalent (irreversible) mutant-selective inhibitor of epidermal growth factor receptor (EGFR) in development for the treatment of EGFR-mutated, T790M positive non-small cell lung cancer (NSCLC), is the subject of four mini-oral presentations and two poster sessions at the 16th World Conference on Lung Cancer. Hosted by the International Association for the Study of Lung Cancer (IASLC), the conference took place September 6-9, 2015 in Denve.